Product image of Multibic (Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc) supplied by GNH India

Multibic

Active Ingredient:
Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc
Origin:
EU

Multibic (Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc)

Sodium hydrogen carbonate, magnesium chloride hexahydrate, potassium chloride, sodium chloride and calcium, the active ingredients in Multibic, are an electrolyte solution presented as a sterile solution for intravenous use during haemodialysis. It provides essential electrolytes and buffering capacity to support acid‑base and electrolyte balance in patients undergoing renal replacement therapy.

GNH India supplies Multibic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and dialysis centres worldwide.

Manufacturer / TM Owner

Fresenius Medical Care Deutschland Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Multibic is used in the context of renal replacement therapy and dialysis to maintain electrolyte and acid‑base homeostasis.

  • Hemodialysis: helps maintain electrolyte concentrations and pH during the dialysis session.
  • Renal replacement therapy: supplies necessary ions when native kidney function is insufficient.
  • Electrolyte replacement during dialysis: prevents deficits of potassium, magnesium, calcium and sodium that can arise from the treatment.

How It Works

  • Multibic delivers sodium, potassium, calcium, magnesium ions and bicarbonate directly into the bloodstream during haemodialysis. The supplied bicarbonate acts as a buffer, correcting metabolic acidosis, while the mineral ions replenish those removed by the dialyzer, thereby preserving plasma electrolyte concentrations and supporting normal cardiac and neuromuscular function.

Side Effects

Multibic may be associated with infusion‑related reactions and electrolyte shifts.

Common Side Effects

  • Mild hypotension: transient drop in blood pressure during infusion.
  • Nausea or vomiting: gastrointestinal discomfort reported by some patients.
  • Headache: occasional mild headache during or after administration.
  • Transient electrolyte shifts: temporary changes in serum potassium or magnesium.
  • Infusion site irritation: redness or mild pain at the catheter site.

Serious or Rare Side Effects

  • Severe hyperkalemia: dangerous rise in potassium levels.
  • Hypermagnesemia: excessive magnesium causing cardiac effects.
  • Anaphylactic reaction: rare severe allergic response.
  • Cardiac arrhythmia: irregular heart rhythm linked to electrolyte imbalance.
  • Severe metabolic alkalosis: excessive bicarbonate leading to high pH.

Precautions & Warnings

Prior assessment and monitoring are essential when using Multibic.

  • Baseline electrolyte assessment: check serum levels before infusion.
  • Blood pressure monitoring: observe for hypotension during administration.
  • Dialysate adjustment: tailor dialysate composition based on patient needs.
  • Cardiac disease caution: use carefully in patients with known arrhythmias.
  • Hypersensitivity avoidance: discontinue if allergic reaction occurs.
  • Store at ambient temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Multibic can interact with other agents that affect electrolyte balance.

Major Interactions (Avoid)

  • High‑potassium supplements: risk of hyperkalemia.
  • Calcium‑containing medications: may cause hypercalcemia.
  • Magnesium‑containing laxatives or antacids: increase risk of hypermagnesemia.
  • Sodium bicarbonate infusions: can lead to severe metabolic alkalosis.

Moderate Interactions (Monitor Closely)

  • Loop diuretics: may amplify electrolyte shifts.
  • Antihypertensive drugs: additive blood pressure lowering effect.
  • Anticoagulants used in dialysis: monitor for bleeding complications.

Frequently Asked Questions

Multibic is an injectable electrolyte solution used during haemodialysis and other forms of renal replacement therapy. It supplies essential ions and bicarbonate to help maintain acid‑base balance and electrolyte homeostasis while patients undergo dialysis.

The formulation provides sodium, potassium, calcium, magnesium and bicarbonate directly into the bloodstream. Bicarbonate buffers metabolic acids, while the mineral ions replace those removed by the dialyzer, supporting normal cellular function and preventing electrolyte disturbances.

The dose of Multibic is determined by the prescribing clinician based on the patient’s dialysis prescription, electrolyte status and overall clinical condition. It is administered intravenously as part of the haemodialysis circuit.

Safety data for Multibic in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by the treating physician.

To order Multibic, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Multibic combines a full complement of sodium, potassium, calcium, magnesium and bicarbonate in a single sterile solution, whereas some alternatives may require separate additives. This integrated approach can simplify preparation and reduce the risk of dosing errors during dialysis.

Multibic should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the container from moisture, direct sunlight and extreme temperature fluctuations to maintain solution stability.

Multibic is administered intravenously, typically added to the dialysis circuit by the healthcare professional overseeing the haemodialysis session. The exact infusion rate and volume are set according to the patient’s treatment plan.

Serious risks include severe hyperkalemia, hypermagnesemia, anaphylactic reactions, cardiac arrhythmias and severe metabolic alkalosis. Continuous monitoring of electrolyte levels and patient vital signs is essential to detect and manage these events promptly.

Multibic should be avoided in patients with known hypersensitivity to any of its components, in those with uncontrolled severe electrolyte imbalances, or in individuals where the risk of severe hyperkalemia, hypermagnesemia or metabolic alkalosis outweighs the therapeutic benefit.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.